Status:
COMPLETED
Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Breast Cancer
Elderly
Eligibility:
FEMALE
70+ years
Brief Summary
The goal is to study the biology of aging in breast cancer patients, and to study the impact of chemotherapy on aging related blood biomarkers.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 70 years or older
- Female
- Early breast cancer
- Candidate for systemic adjuvant therapy
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00849758
Start Date
May 1 2009
End Date
September 1 2014
Last Update
December 9 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jules Bordet Institute
Brussels, Belgium, 1000
2
University Hospitals Leuven
Leuven, Belgium, 3000